In this episode, we sit down with George Tice, executive director public policy Elanco to learn about Avilamycin’s global footprint, quality and particle size.
Avilamycin was introduced across the world in 1987 and is currently being used in more than 40 countries, including the U.S., Brazil, Canada, and Japan, and therefore in billions of broilers every year.
What about its safety? With the long history of use of Avilamycin, there have been no concerns regarding antimicrobial resistance in humans. And that’s because it belongs to the antimicrobial class Orthosomycins. And, that class is not used in human medicine. So, no antimicrobial resistance concerns. Secondly, no residue concerns. It has an excellent residue profile and that’s because there is very little absorption in the bird’s gastrointestinal tract.
What about its quality? Avilamycin is manufactured in Speke, England, and it’s a complex manufacturing process that the plant in Speke has mastered. And we ensure high quality and product consistency. What we mean by that, firstly, is the right potency in every batch with the right amount of active ingredient. Secondly, the right formulation. The components of the right formulation include a high-quality granule, which is not dusty and flows freely, and the right particle size distribution, leading to better mixability and better distribution in feed.
What about its traceability? Elanco can trace the identity, history and source of all the raw materials, ingredients and feed stocks used in the manufacturing of Avilamycin. And of course, we keep meticulous records at all stages in the production system. So, Avilamycin has a long history of safety, consistent potency, granular and particle size formulation and traceability. This provides customers with peace of mind by delivering the correct dose to every bird, every day during the treatment period.
Take a look at the previous 3 videos from the series
"*" indicates required fields
Intestinal Integrity Corner, produced by Elanco, brings you insights into threats to broiler gut health and how to mitigate them with strategies for prevention, management and disease treatment that reduce reliance on medically important antibiotics. Elanco is committed to the poultry industry, delivering important scientific information about Intestinal Integrity, technical expertise, customer support and proven products such as Maxiban and Monteban. Maxiban and Monteban together form a trusted solution to maintain optimal enteric health resulting in efficient, healthy birds to promote safer food, better economic return and more brand assurance. Elanco is a global animal health company that develops products and knowledge services to prevent and treat disease in farm animals and pets in more than 90 countries. Elanco creates innovative solutions through products and services that address the challenges of an ever-changing world and empower those who raise and care for animals. Visit the Elanco website for more information
Intestinal Integrity Corner, produced by Elanco, brings you insights into threats to broiler gut health and how to mitigate them with strategies for prevention, management and disease treatment that reduce reliance on medically important antibiotics. Elanco is committed to the poultry industry, delivering important scientific information about Intestinal Integrity, technical expertise, customer support and proven products such as Maxiban and Monteban. Maxiban and Monteban together form a trusted solution to maintain optimal enteric health resulting in efficient, healthy birds to promote safer food, better economic return and more brand assurance. Elanco is a global animal health company that develops products and knowledge services to prevent and treat disease in farm animals and pets in more than 90 countries. Elanco creates innovative solutions through products and services that address the challenges of an ever-changing world and empower those who raise and care for animals. Visit the Elanco website for more information
Notifications
Your Privacy Matters
It's your legal right to choose which information a website may store and have access to. With your permission, we and our third-party partners (24) store and/or access information on a device, such as unique identifiers in cookies and browsing data to collect and process personal data.
We and our partners do the following data processing:
Store and/or access information on a device, Advertising based on limited data and advertising measurement, Personalised content, content measurement, audience research, and services development
If you accept any or all of these, you will have agreed to this website's use of cookies for these purposes. You may also choose to refuse consent, but certain personalized features of the site won't be available to you.